1. Alfa Wassermann, Inc. (21 from 88 patents)

2. Salix Pharmaceuticals, Inc. (3 from 63 patents)

3. Alfasigma S.p.a. (1 from 22 patents)

4. Manuela Campana (0 patent)

5. Goffredo Rosini (0 patent)

6. Vincenzo Cannata (0 patent)

7. Dario Braga (0 patent)

8. Donatella Confortini (0 patent)

9. Giuseppe C. Viscomi (0 patent)

10. Denis Severini (0 patent)

11. Paolo Righi (0 patent)

1. 10703763 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

2. 9725466 - Rifaximin derivative and uses thereof

3. 9498442 - Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

4. 9364467 - Rifaximin derivative and uses thereof

5. 9271968 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

6. 9035046 - Rifaximin derivative and uses thereof

7. 8853231 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin

8. 8835452 - Polymorphic forms α, β and γ of rifaximin

9. 8748447 - Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

10. 8741904 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

11. 8518949 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

12. 8404704 - Use of polymorphic forms of rifaximin for medical preparations

13. 8193196 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations

14. 8173801 - Processes for the production of polymorphic forms of rifaximin

15. 8158644 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin